DOCSLIB.ORG

The Effects of Acute Nicotinamide Riboside Supplementation

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
The Effects of Acute Nicotinamide Riboside Supplementation THE EFFECTS OF ACUTE NICOTINAMIDE RIBOSIDE SUPPLEMENTATION ON SUBSTRATE UTILISATION AND 5KM TIME-TRIAL PERFORMANCE By ELIZABETH LOUISE GRAY A thesis submitted to The University of Birmingham for the degree of MASTERS BY RESEARCH School of Sport, Exercise and Rehabilitation Sciences College of Life and Environmental Studies University of Birmingham August 2018 University of Birmingham Research Archive e-theses repository This unpublished thesis/dissertation is copyright of the author and/or third parties. The intellectual property rights of the author or third parties in respect of this work are as defined by The Copyright Designs and Patents Act 1988 or as modified by any successor legislation. Any use made of information contained in this thesis/dissertation must be in accordance with that legislation and must be properly acknowledged. Further distribution or reproduction in any format is prohibited without the permission of the copyright holder. ABSTRACT Nicotinamide Riboside (NR) administration has been shown to increase fat oxidation and improve endurance performance in rodents, whilst recent research has proven it is safe for human consumption. The present study aimed to investigate the influence of acute NR supplementation on substrate utilisation and exercise performance in humans. In this counter-balanced, crossover design study, eleven recreationally-active males performed a 60-minute bout of cycling at 55% VO2max, followed by a 5km time-trial. Participants completed this twice during visits separated by at least one week, once following the consumption of 1000mg NR, and the other following placebo consumption. The contribution of fat oxidation to total substrate utilisation was not significantly different between the NR and placebo conditions during steady-state exercise (22.3±9.0% and 19.6±7.3%, respectively; p < 0.05). Similarly, there were no significant differences shown between 5km time-trial performance with NR (823.4±250.0 seconds) and placebo (819.5±239.8 seconds). To conclude, a single dose of NR does not influence substrate utilisation during moderate-intensity exercise, nor does it enhance exercise performance. Future research should investigate the effects of chronic NR supplementation, or the coupling of this with exercise training to further test the capacity of NR in humans during exercise. ACKNOWLEDGEMENTS Foremost, I would like to express my thanks to my thesis supervisor Dr Andrew Philp previously of the School of Sport, Exercise and Rehabilitation Sciences at the University of Birmingham, who now however resides in Australia working for the Garvan Institute of Medical Research. Not only did Dr Philp encourage me to join his research team and enter postgraduate study, but also provided help and guidance whenever necessary. I would also like to thank the remainder of the Philp lab for welcoming me into their team and for always answering any queries I may have had. A special thank you to Mr Ben Stocks and Ms Joanna Worthington for their assistance in the collection of the data presented in this thesis, and for their constant support throughout the duration of my studies. Additionally, my fellow Masters students have made my time studying in Birmingham very enjoyable, alongside always being there to lend a hand or offer advice and guidance, and I would like to thank them for this. Last but not least, I would like to thank my family and friends for their continued support throughout both my undergraduate and postgraduate studies. TABLE OF CONTENTS Introduction 1 Substrate utilisation 2 Factors affecting substrate utilisation 3 Fatmax 4 Control of substrate utilisation 5 Hormonal control of substrate utilisation 6 Molecular control of substrate utilisation 8 Nutrition 10 Nutritional supplements 12 NAD+ 14 NAD+ concentrations 15 NAD+ and exercise 16 NAD+ consumers 16 NAD+ biosynthesis 17 Depleted NAD+ levels 18 Nicotinamide riboside 19 NR supplementation in humans 21 NR dosing strategies 23 Hypotheses 26 Methodology 27 Participants 27 Study design 28 Details of laboratory visits 29 Randomisation and blinding 33 Supplementation 34 Nutrition and physical activity controls 35 Cannulation 35 Blood preparation 36 Blood analysis 37 Calculations 39 Statistical analysis 39 Results 40 Workload 40 Oxygen consumption and carbon dioxide production 40 Respiratory exchange ratio 41 Fat and carbohydrate oxidation 42 Heart rate 46 Ratings of perceived exertion 46 Time trial performance 48 Plasma metabolites 49 Discussion 53 Substrate utilisation 55 Time trial performance 57 Implications 59 Future direction 60 Conclusion 63 References 64 LIST OF ILLUSTRATIONS LIST OF FIGURES Figure 1. Schematic of the determinants of performance 2 Figure 2. Molecular control of fat oxidation 10 Figure 3. NAD+ biosynthesis 18 Figure 4: PBMC NAD+ concentration following consumption of 22 1,000mg NR daily for seven days Figure 5: NAD+ metabolite AUC increase from baseline (%) in 23 response to 100mg, 300mg and 1,000mg doses of NR Figure 6. Experimental trial schematic 33 Figure 7. Mean RER vs. time (minutes) throughout steady-state 42 exercise Figure 8. Mean fat and CHO oxidation rates vs. time (minutes) 44 throughout steady-state exercise, NR vs. placebo Figure 9. Mean substrate contribution (%) vs. time (minutes) 45 throughout steady-state exercise, NR vs. placebo Figure 10. Mean HR and RPE vs. time (minutes) throughout steady- 47 state exercise, NR vs. placebo Figure 11. Mean 5km time-trial performance time (seconds), NR vs. 49 placebo Figure 12. Mean plasma concentrations vs. time throughout steady- 51 - 52 state exercise and post time-trial, NR vs. placebo LIST OF TABLES Table 1. Participant characteristics 28 Table 2. Mean VO2 and VCO2 values for NR and placebo conditions 41 at baseline and during steady-state exercise LIST OF ABBREVIATIONS ADP Adenosine diphosphate AMP Adenosine monophosphate AMPK AMP-activated protein kinase ATP Adenosine triphosphate CHO Carbohydrate EDTA Ethylenediamine tetraacetic acid ERR Estrogen-related receptor FA Fatty acid GTE Green tea extract NA Nicotinic acid NAAD+ Nicotinic acid adenine dinucleotide NAD Nicotinamide adenine dinucleotide NAMN Nicotinic acid mononucleotide NEFA Non-esterified fatty acids NMN Nicotinamide mononucleotide NR Nicotinamide riboside NRK Nicotinamide riboside kinase PARP Poly-ADP-ribose polymerases PBMC Peripheral blood mononuclear cell PGC-1α PPAR-y coactivator-1α PPAR Peroxisome proliferator-activated receptor RER Respiratory exchange ratio RPE Ratings of perceived exertion TF Transcription factor VE Minute ventilation WT Wild type INTRODUCTION Regular physical activity is a preventative strategy for various chronic diseases such as type 2 diabetes, cardiovascular disease, hypertension and obesity (Warburton, Nicol & Bredin, 2006). Performing repeated bouts of exercise will, over time, induce various physiological adaptations that also facilitate an improvement in exercise performance (Jones & Carter, 2000). The type of training undertaken, such as endurance or resistance, determines the nature and magnitude of these changes (Jones & Carter, 2000). Joyner & Coyle (2008) present a model of the multiple physiological factors that interact as determinants of performance (see Figure 1). Ultimately, they propose that exercise performance is determined by a combination of mechanical, cardiovascular, molecular, respiratory and anthropometric factors. The model suggests that morphological components such as stroke volume, haemoglobin content, aerobic enzyme activity and skeletal muscle fibre type together determine whole-body performance markers, such as maximal oxygen consumption (VO2max), lactate threshold, mechanical efficiency and buffering capacity. These markers then interact at the whole-body level to determine the velocity and/or power of any given activity performed (Joyner & Coyle, 2008). Thus, changing any of these components has the potential to enhance these performance markers, and hence performance itself. 1 Performance Velocity or Power PerformanceP VO2 + Performance X Gross Mechanical ( (aerobic) O2deficit (anaerobic)) ) Efficiency Lactate Total Buffering Threshold VO2 Capacity Maximal Oxygen Consumption Muscle Stroke Max Haemo Aerobic Distribution % Slow Anthro- Capillary Volume Heart -globin Enzyme of Power Twitch pometry and Density Rate Conten Activity Output Muscle Fibres Elasticity MORPHOLOGICAL COMPONENTS Figure 1. Schematic of the determinants of performance (reproduced from Joyner & Coyle, 2008) SUBSTRATE UTLISATION An additional factor that also influences performance is the contribution of fuels used during exercise. It is well known that carbohydrates (CHO) and fats are the dominant substrates oxidised in skeletal muscle during exercise in humans (Spriet, 2002), with a very minor contribution from protein. In comparison to CHO, fat is much more energy dense and is largely stored within the body – primarily in adipose tissue and as triglycerides within the muscle (Spriet, 2002). Following food consumption, macronutrients themselves do not directly provide energy – they require oxidation which releases adenosine triphosphate (ATP), and finally energy for work is released once ATP is hydrolysed (Melzer, 2011). The magnitude of energy expenditure, i.e. the intensity of exercise, is a determinant of whether this energy is generated anaerobically 2 or aerobically. During light exercise, aerobic respiration almost solely provides the energy required, however as this intensity increases, reliance on the anaerobic system becomes greater (Melzer, 2011). Although
Load more

Recommended publications
  • Chem331 Glycogen Metabolism
    Glycogen metabolism Glycogen review - 1,4 and 1,6 α-glycosidic links ~ every 10 sugars are branched - open helix with many non-reducing ends. Effective storage of glucose Glucose storage Liver glycogen 4.0% 72 g Muscle glycogen 0.7% 245 g Blood Glucose 0.1% 10 g Large amount of water associated with glycogen - 0.5% of total weight Glycogen stored in granules in cytosol w/proteins for synthesis, degradation and control There are very different means of control of glycogen metabolism between liver and muscle Glycogen biosynthetic and degradative cycle Two different pathways - which do not share enzymes like glycolysis and gluconeogenesis glucose -> glycogen glycogenesis - biosynthetic glycogen -> glucose 1-P glycogenolysis - breakdown Evidence for two paths - Patients lacking phosphorylase can still synthesize glycogen - hormonal regulation of both directions Glycogenolysis (glycogen breakdown)- Glycogen Phosphorylase glycogen (n) + Pi -> glucose 1-p + glycogen (n-1) • Enzyme binds and cleaves glycogen into monomers at the end of the polymer (reducing ends of glycogen) • Dimmer interacting at the N-terminus. • rate limiting - controlled step in glycogen breakdown • glycogen phosphorylase - cleavage of 1,4 α glycosidic bond by Pi NOT H2O • Energy of phosphorolysis vs. hydrolysis -low standard state free energy change -transfer potential -driven by Pi concentration -Hydrolysis would require additional step s/ cost of ATP - Think of the difference between adding a phosphate group with hydrolysis • phosphorylation locks glucose in cell (imp. for muscle) • Phosphorylase binds glycogen at storage site and the catalytic site is 4 to 5 glucose residues away from the catalytic site. • Phosphorylase removes 1 residue at a time from glycogen until 4 glucose residues away on either side of 1,6 branch point – stericaly hindered by glycogen storage site • Cleaves without releasing at storage site • general acid/base catalysts • Inorganic phosphate attacks the terminal glucose residue passing through an oxonium ion intermediate.
    [Show full text]
  • Glycogenosis Due to Liver and Muscle Phosphorylase Kinase Deficiency
    Pediat. Res. 15: 299-303 (198 1) genetics muscle glycogenosis phosphorylase kinase deficiency liver Glycogenosis Due to Liver and Muscle Phosphorylase Kinase Deficiency N. BASHAN. T. C. IANCU. A. LERNER. D. FRASER, R. POTASHNIK. AND S. W. MOSES'"' Pediatric Research Laborarorv. Soroka Medical Center. Iaculr~of Health Sciences. Ben-Gurion Universi!,' of Negev. Beer-Sheva, and Department of Pediatrics. Carmel Hospiral. Huifa. Israel Summary hepatomegaly. The family history disclosed that two sisters were similarly affected, whereas one older brother was apparently A four-year-old Israeli Arab boy was found to have glycogen healthy. accumulation in both liver and muscle without clinical symptoms. Past history was unremarkable. The patient's height was below Liver phosphorylase kinase (PK) activity was 20% of normal, the third percentile for his age in contrast to a normal weight. He resulting in undetectable activity of phosphorylase a. Muscle PK had a doll face and a protuberant abdomen. The liver was palpable activity was about 25% of normal, resulting in a marked decrease 9 cm below the costal margin. Slight muscular hypotonia and of phosphorylase a activity. weakness were noticeable with normal tendon reflexes. He had Two sisters showed a similar pattern, whereas one brother had slightly abnormal liver function tests. a fasting blood sugar of 72 normal PK activity. The patient's liver protein kinase activity was mg %, a normal glucagon test. and no lactic acidemia or uricemia normal. Addition of exogenous protein kinase did not affect PK but slight lipidemia. Electronmicroscopic studies of a liver biopsy activity, whereas exogenous PK restored phosphorylase activity revealed marked deposition of glycogen.
    [Show full text]
  • Muscle Glycogen Phosphorylase and Its Functional Partners in Health and Disease
    cells Review Muscle Glycogen Phosphorylase and Its Functional Partners in Health and Disease Marta Migocka-Patrzałek * and Magdalena Elias Department of Animal Developmental Biology, Faculty of Biological Sciences, University of Wroclaw, 50-335 Wroclaw, Poland; [email protected] * Correspondence: [email protected] Abstract: Glycogen phosphorylase (PG) is a key enzyme taking part in the first step of glycogenolysis. Muscle glycogen phosphorylase (PYGM) differs from other PG isoforms in expression pattern and biochemical properties. The main role of PYGM is providing sufficient energy for muscle contraction. However, it is expressed in tissues other than muscle, such as the brain, lymphoid tissues, and blood. PYGM is important not only in glycogen metabolism, but also in such diverse processes as the insulin and glucagon signaling pathway, insulin resistance, necroptosis, immune response, and phototransduction. PYGM is implicated in several pathological states, such as muscle glycogen phosphorylase deficiency (McArdle disease), schizophrenia, and cancer. Here we attempt to analyze the available data regarding the protein partners of PYGM to shed light on its possible interactions and functions. We also underline the potential for zebrafish to become a convenient and applicable model to study PYGM functions, especially because of its unique features that can complement data obtained from other approaches. Keywords: PYGM; muscle glycogen phosphorylase; functional protein partners; glycogenolysis; McArdle disease; cancer; schizophrenia Citation: Migocka-Patrzałek, M.; Elias, M. Muscle Glycogen Phosphorylase and Its Functional Partners in Health and Disease. Cells 1. Introduction 2021, 10, 883. https://doi.org/ The main energy substrate in animal tissues is glucose, which is stored in the liver and 10.3390/cells10040883 muscles in the form of glycogen, a polymer consisting of glucose molecules.
    [Show full text]
  • Lehrstuhl Für Technische Mikrobiologie Sucrose Metabolism
    Lehrstuhl für Technische Mikrobiologie Sucrose metabolism in lactobacilli and bifidobacteria Susanne B. Kaditzky Vollständiger Abdruck der von der Fakultät Wissenschaftszentrum Weihenstephan für Ernährung, Landnutzung und Umwelt der Technischen Universität München zur Erlangung des akademischen Grades eines Doktors der Naturwissenschaften (Dr. rer. nat.) genehmigten Dissertation. Vorsitzender: Univ.-Prof. Dr.-Ing., Dr.-Ing. habil. Werner Back Prüfer der Dissertation: 1. Univ.-Prof. Dr. rer. nat. habil. Rudi F. Vogel 2. Univ.-Prof. Dr. rer. nat. habil. Siegfried Scherer 3. Ass. Prof. Dr. rer. nat. Michael Gänzle, University of Alberta / Kanada (schriftliche Beurteilung) Die Dissertation wurde am 25.10.2007 bei der Technischen Universität München eingereicht und durch die Fakultät Wissenschaftszentrum Weihenstephan für Ernährung, Landnutzung und Umwelt am 07.01.2008 angenommen. Lehrstuhl für Technische Mikrobiologie Sucrose metabolism in lactobacilli and bifidobacteria Susanne B. Kaditzky Doctoral thesis Fakultät Wissenschaftszentrum Weihenstephan für Ernährung, Landnutzung und Umwelt Freising 2008 Mein Dank gilt Rudi Vogel für die Überlassung des Themas und seine geduldige und unterstützende Begleitung durch die lehrreichen und interessanten Jahre, Michael Gänzle, Maher Korakli und Daniel Meissner für ihr Engagement und ihre Unterstützung, allen Kollegen für das gute und humorvolle Arbeitsklima, Andreas Stocker für die Charakterisierung des EPS mit FFF, Peter Kaden für die NMR- Analyse und Jürgen Behr für die Durchführung der 2D-Experimente,
    [Show full text]
  • O-Glcnacylation Is a Key Regulator of Multiple Cellular Metabolic Pathways
    O-GlcNAcylation is a key regulator of multiple cellular metabolic pathways Hongshuo Zhang, Zhen Li, Yufei Wang and Ying Kong Core Laboratory of Glycobiology and Glycoengineering, College of Basic Medical Sciences, Dalian Medical University, Dalian, Liaoning, China ABSTRACT O-GlcNAcylation modifies proteins in serine or threonine residues in the nucleus, cytoplasm, and mitochondria. It regulates a variety of cellular biological processes and abnormal O-GlcNAcylation is associated with diabetes, cancer, cardiovascular disease, and neurodegenerative diseases. Recent evidence has suggested that O-GlcNAcylation acts as a nutrient sensor and signal integrator to regulate metabolic signaling, and that dysregulation of its metabolism may be an important indicator of pathogenesis in disease. Here, we review the literature focusing on O-GlcNAcylation regulation in major metabolic processes, such as glucose metabolism, mitochondrial oxidation, lipid metabolism, and amino acid metabolism. We discuss its role in physiological processes, such as cellular nutrient sensing and homeostasis maintenance. O-GlcNAcylation acts as a key regulator in multiple metabolic processes and pathways. Our review will provide a better understanding of how O-GlcNAcylation coordinates metabolism and integrates molecular networks. Subjects Biochemistry, Cell Biology, Metabolic Sciences Keywords O-GlcNAc, Nutrient sensing, Glucose uptake, Glycolysis, Mitochondria, Lipid metabolism, Glutamine, Signaling pathway, Homeostasis, TCA INTRODUCTION Increasing evidence has suggested
    [Show full text]
  • Skeletal Muscle Gene Expression in Long-Term Endurance and Resistance Trained Elderly
    International Journal of Molecular Sciences Article Skeletal Muscle Gene Expression in Long-Term Endurance and Resistance Trained Elderly 1,2, 3, 1,2, Alessandra Bolotta y, Giuseppe Filardo y, Provvidenza Maria Abruzzo *, Annalisa Astolfi 4,5 , Paola De Sanctis 1, Alessandro Di Martino 6, Christian Hofer 7, Valentina Indio 4 , Helmut Kern 7, Stefan Löfler 7 , Maurilio Marcacci 8, Sandra Zampieri 9,10, 1,2, 1, Marina Marini z and Cinzia Zucchini z 1 Department of Experimental, Diagnostic and Specialty Medicine, University of Bologna School of Medicine, 40138 Bologna, Italy; [email protected] (A.B.); [email protected] (P.D.S.); [email protected] (M.M.); [email protected] (C.Z.) 2 IRCCS Fondazione Don Carlo Gnocchi, 20148 Milan, Italy 3 Applied and Translational Research Center, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy; g.fi[email protected] 4 Giorgio Prodi Interdepartimental Center for Cancer Research, S.Orsola-Malpighi Hospital, 40138 Bologna, Italy; annalisa.astolfi@unibo.it (A.A.); [email protected] (V.I.) 5 Department of Morphology, Surgery and Experimental Medicine, University of Ferrara, 44121 Ferrara, Italy 6 Second Orthopaedic and Traumatologic Clinic, IRCCS Istituto Ortopedico Rizzoli, 40136 Bologna, Italy; [email protected] 7 Ludwig Boltzmann Institute for Rehabilitation Research, 1160 Wien, Austria; [email protected] (C.H.); [email protected] (H.K.); stefan.loefl[email protected] (S.L.) 8 Department of Biomedical Sciences, Knee Joint Reconstruction Center, 3rd Orthopaedic Division, Humanitas Clinical Institute, Humanitas University, 20089 Milan, Italy; [email protected] 9 Department of Surgery, Oncology and Gastroenterology, University of Padua, 35122 Padua, Italy; [email protected] 10 Department of Biomedical Sciences, University of Padua, 35131 Padua, Italy * Correspondence: [email protected]; Tel.: +39-051-2094122 These authors contributed equally to this work.
    [Show full text]
  • Glycogen Metabolism Glycogen Breakdown Glycogen Synthesis
    Glycogen Metabolism Glycogen Breakdown Glycogen Synthesis Control of Glycogen Metabolism Glycogen Storage Diseases Glycogen Glycogen - animal storage glucan 100- to 400-Å-diameter cytosolic granules up to 120,000 glucose units α(1 → 6) branches every 8 to 12 residues muscle has 1-2% (max) by weight liver has 10% (max) by weight ~12 hour supply Although metabolism of fat provides more energy: 1. Muscle mobilize glycogen faster than fat 2. Fatty acids of fat cannot be metabolized anaerobically 3. Animals cannot convert fatty acid to glucose (glycerol can be converted to glucose) Glycogen Breakdown Three enzymes: glycogen phosphorylase glycogen debranching enzyme phosphoglucomutase Glycogen phosphorylase (phosphorylase) - phosphorolysis of glucose residues at least 5 units from branch point Glycogen + Pi glycogen + glucose-1-phosphate (n residues) (n-1 residues) homodimer of 842-residues (92-kD) subunits allosteric regulation - inhibitors (ATP, glucose-6- phosphate, glucose) and activator (AMP), T ⇔ R covalent modification (phosphorylation) - modification/demodification 2- phosphorylase a (active, SerOPO3 ) phosphorylase b (less active, Ser) narrow 30-Å crevice binds glycogen, accommodates 4 to 5 residues Pyridoxal-5-phosphate (vit B6 derivative) cofactor - located near active site, general acid-base catalyst Rapid equilibrium Random Bi Bi kinetics Glycogen Breakdown Glycogen debranching enzyme - possesses two activities α(1 → 4) transglycosylase (glycosyl transferase) 90% glycogen → glucose-1-phosphate transfers trisaccharide unit from
    [Show full text]
  • Association of Glycogen Synthase Phosphatase And
    ASSOCIATION OF GLYCOGEN SYNTHASE PHOSPHATASE AND PHOSPHORYLASE PHOSPHATASE ACTIVITIES WITH MEMBRANES OF HEPATIC SMOOTH ENDOPLASMIC RETICULUM Downloaded from http://rupress.org/jcb/article-pdf/83/2/348/1074048/348.pdf by guest on 26 September 2021 R . N . MARGOLIS, R . R . CARDELL, and R . T . CURNOW From the Departments of Anatomy, Internal Medicine, and Pharmacology, University of Virginia School of Medicine, Charlottesville, Virginia 22908 ABSTRACT A detailed investigation was conducted to determine the precise subcellular localization ofthe rate-limiting enzymes of hepatic glycogen metabolism (glycogen synthase and phosphorylase) and their regulatory enzymes (synthase phosphatase and phosphorylase phosphatase) . Rat liver was homogenized and fractionated to produce soluble, rough and smooth microsomal fractions . Enzyme assays of the fractions were performed, and the results showed that glycogen synthase and phosphorylase were located in the soluble fraction of the livers . Synthase phos- phatase and phosphorylase phosphatase activities were also present in soluble fractions, but were clearly identified in both rough and smooth microsomal fractions . It is suggested that the location of smooth endoplasmic reticulum (SER) within the cytosome forms a microenvironment within hepatocytes that establishes conditions necessary for glycogen synthesis (and degradation) . Thus the location of SER in the cell determines regions of the hepatocyte that are rich in glycogen particles . Furthermore, the demonstration of the association of synthase phospha- tase and phosphorylase phosphatase with membranes of SER may account for the close morphological association of SER with glycogen particles (i .e ., disposition of SER membranes brings the membrane-bound regulatory enzymes in close contact with their substrates) . KEY WORDS smooth endoplasmic reticulum less clear .
    [Show full text]
  • Glycogen Metabolism CH2OH CH2OH Glycogen H O H H O H H H OH H OH H 1 O OH O H OH H OH
    Glycogen Metabolism CH2OH CH2OH glycogen H O H H O H H H OH H OH H 1 O OH O H OH H OH CH2OH CH2OH 6 CH2 CH2OH CH2OH H O HH O H H 5 O H H O H H O H H H H H H 1 4 OH H OH H 4 OH H OH H OH H O O O O OH OH 3 2 H OH H OH H OH H OH H OH Glycogen is a polymer of glucose residues linked by (14) glycosidic bonds, mainly (16) glycosidic bonds, at branch points. Glycogen chains & branches are longer than shown. Glucose is stored as glycogen predominantly in liver and muscle cells. CH2OH H O H H OH H 2 Glycogen catabolism OH OPO3 H OH (breakdown): glucose-1-phosphate Glycogen Phosphorylase catalyzes phosphorolytic cleavage of the (14) glycosidic linkages of glycogen, releasing glucose‐1‐phosphate as reaction product. glycogen(n residues) +Pi glycogen (n–1 residues) +glucose‐1‐phosphate This phosphorolysis may be compared to hydrolysis: Hydrolysis: R-O-R' + HOH R-OH + R'-OH 2- 2- Phosphorolysis: R-O-R' + HO-PO3 R-OH + R'-O-PO3 Pyridoxal phosphate (PLP), H O O C a derivative of vitamin B , O H2 6 PC OH serves as prosthetic group O O for Glycogen N CH3 Phosphorylase. H pyridoxal phosphate (PLP) lysine Enz H (CH2)4 H N+ CCOO 3 N+ CH O HC H 2 O H2 P C O CH2 O O CH2 CH2 N CH3 H NH3 Enzyme (Lys)-PLP Schiff base Pyridoxal phosphate (PLP) is held at the active site by a Schiff base linkage, formed by reaction of the aldehyde of PLP with the ‐amino group of a lysine residue.
    [Show full text]
  • Factors Influencing Glycogen Branching Enzyme Activity in Mouse
    Louisiana State University LSU Digital Commons LSU Doctoral Dissertations Graduate School 2013 Factors influencing glycogen branching enzyme activity in mouse liver Scott ulF ler Louisiana State University and Agricultural and Mechanical College, [email protected] Follow this and additional works at: https://digitalcommons.lsu.edu/gradschool_dissertations Part of the Kinesiology Commons Recommended Citation Fuller, Scott, "Factors influencing glycogen branching enzyme activity in mouse liver" (2013). LSU Doctoral Dissertations. 2022. https://digitalcommons.lsu.edu/gradschool_dissertations/2022 This Dissertation is brought to you for free and open access by the Graduate School at LSU Digital Commons. It has been accepted for inclusion in LSU Doctoral Dissertations by an authorized graduate school editor of LSU Digital Commons. For more information, please [email protected]. FACTORS INFLUENCING GLYCOGEN BRANCHING ENZYME ACTIVITY IN MOUSE LIVER A Dissertation Submitted to the Graduate Faculty of the Louisiana State University and Agricultural and Mechanical College in partial fulfillment of the requirements for the degree of Doctor of Philosophy in The Department of Kinesiology by Scott Fuller B.A. Louisiana State University, 1993 M.P.A. Louisiana State University, 1998 M.S. Louisiana State University, 2005 May 2013 ACKNOWLEDGMENTS The completion of a dissertation is never the result of a single individual’s effort. Indeed, this project would never have been seen through to the end without the devotion, patience, and inspired ideas of several academic professionals whose dedication to scientific inquiry sustained this enterprise. First and foremost, I owe an immense debt of gratitude to my doctoral mentor, Dr. Arnold Nelson. His wealth of experience, unique perspectives, sharp intellect, and patient guidance were all instrumental in allowing this project to progress to completion.
    [Show full text]
  • The Crosstalk Between O-Glcnacylation and Phosphorylation in Insulin Signaling
    THE CROSSTALK BETWEEN O-GLCNACYLATION AND PHOSPHORYLATION IN INSULIN SIGNALING by Ping Hu A dissertation submitted to Johns Hopkins University in conformity with the requirements for the degree of Doctor of Philosophy Baltimore, Maryland December, 2015 © Ping Hu All Rights Reserved ABSTRACT Extensive crosstalk between phosphorylation and O-GlcNAcylation is involved in regulating insulin signaling. In addition, many of the key regulators of insulin signaling have been shown to be O-GlcNAcylated. In this study, we first explored the crosstalk between phosphorylation and O-GlcNAcylation globally, and then focused on an upstream signaling regulator key to insulin signaling, insulin receptor substrate 1, IRS1. Through regulating cellular O-GlcNAcylation levels in differentiated adipocyte 3T3-L1 cells by specific OGT and OGA inhibitors, we measured the affects of O-GlcNAcylation on the phosphorylation status of key molecules. We observed that O-GlcNAcylation regulates the flux through the two main divergent cellular pathways of insulin signaling, one regulating glucose metabolism and the other regulating cellular proliferation via MAP kinase. Decreased O-GlcNAcylation was associated with increased glucose utilization, and increased O-GlcNAcylation was associated with increased insulin-induced cellular proliferation pathways. Since IRS1 is early in the insulin signaling pathway and is both highly O-GlcNAcylated and highly phosphorylated, we focused on the crosstalk of those two PTMs on IRS1. The phosphorylation spectrum of IRS1 revealed by 2D electrophoretic analyses, partially explained why decreased O-GlcNAcylation facilitated glucose uptake. Two new O- GlcNAcylation sites were mapped through CID/ETD mass spectrometry. With help of protein truncation and site mutagenesis techniques, we propose a mechanism suggesting that the O-GlcNAcylation of Ser635, may be a negative regulator of the C-terminal O- GlcNAcylations on IRS1.
    [Show full text]
  • Metabolism of Oligosaccharides and Starch in Lactobacilli: a Review
    REVIEW ARTICLE published: 26 September 2012 doi: 10.3389/fmicb.2012.00340 Metabolism of oligosaccharides and starch in lactobacilli: a review Michael G. Gänzle* and Rainer Follador † Department of Agricultural, Food and Nutritional Science, University of Alberta, Edmonton, AB, Canada Edited by: Oligosaccharides, compounds that are composed of 2–10 monosaccharide residues, are Kostas Koutsoumanis, Aristotle major carbohydrate sources in habitats populated by lactobacilli. Moreover, oligosaccharide University, Greece metabolism is essential for ecological fitness of lactobacilli. Disaccharide metabolism by Reviewed by: Eva Van Derlinden, Katholieke lactobacilli is well understood; however, few data on the metabolism of higher oligosac- Universiteit Leuven, Belgium charides are available. Research on the ecology of intestinal microbiota as well as the com- Alexandra Lianou, Aristotle University mercial application of prebiotics has shifted the interest from (digestible) disaccharides to of Thessaloniki, Greece (indigestible) higher oligosaccharides.This review provides an overview on oligosaccharide *Correspondence: metabolism in lactobacilli. Emphasis is placed on maltodextrins, isomalto-oligosaccharides, Michael G. Gänzle, Department of Agricultural, Food and Nutritional fructo-oligosaccharides, galacto-oligosaccharides, and raffinose-family oligosaccharides. Science, University of Alberta, 4-10 Starch is also considered. Metabolism is discussed on the basis of metabolic studies Ag/For Centre, Edmonton, AB, related to oligosaccharide metabolism, information on the cellular location and substrate Canada T6G 2P5. specificity of carbohydrate transport systems, glycosyl hydrolases and phosphorylases, e-mail: [email protected] and the presence of metabolic genes in genomes of 38 strains of lactobacilli. Metabolic †Present address: Rainer Follador, Microsynth AG, pathways for disaccharide metabolism often also enable the metabolism of tri- and tetrasac- Balgach, Switzerland.
    [Show full text]